(CTN News) – A drug used to treat Advanced Lymphoma has been recommended by the National Institute for Health and Care Excellence (NICE) as a new treatment option for patients with advanced lymphoma. Bispecific monoclonal antibodies (BsAbs) are indicated for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two […]
This post first appeared on Data Analytics Can Be A Powerful Tool Against Cybercrime’s Meteoric Rise In South East Asia, please read the originial post: here
